Universal Vision Biotechnology Co., Ltd. operates within the Ophthalmic goods sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Universal Vision Biotechnology Co., Ltd. with three other
miscellaneous wholesalers in Asia:
Phol Dhanya Public Company Limited
sales of 1.10 billion Thai Bahts [US$35.23 million]
Global Energy Resources International Group Limited
of Hong Kong
(276.37 million Hong Kong Dollars [US$35.25 million]
China Strategic Holdings Limited
based in Hong Kong
(270.71 million Hong Kong Dollars [US$34.52 million]
of which 33%
was Investments in Securities).
During the year ended December of 2016, sales at
Universal Vision Biotechnology Co., Ltd. were 1.07 billion Taiwanese Dollars (US$36.74 million).
increase of 5.8%
versus 2015, when the company's sales were 1.01 billion Taiwanese Dollars.
This was the fourth straight year of sales growth at Universal Vision Biotechnology Co., Ltd..
Sales of Medical Treatment Operation saw an increase
that was more than double the company's growth rate: sales were up
12.8% in 2016, from
549.96 million Taiwanese Dollars to 620.55 million Taiwanese Dollars.
Not all segments of Universal Vision Biotechnology Co., Ltd. experienced an increase in sales in 2016:
sales of Ophthalmic Goods Manufacturing fell 2.6% to 452.43 million Taiwanese Dollars.